An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
This treatment has been approved for sale to the public.
Information provided by:
First received: July 3, 2009
Last updated: November 29, 2016
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This treatment has been approved for sale to the public.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||June 2008 (Final data collection date for primary outcome measure)|